In contrast to MCT1 and MCT4, which were mainly described at the plasma membrane in a wide variety of malignancies, MCT2 expression in human cancers was always less evident and, when present, its expression was mainly cytoplasmic 23. The gene discussed is SLC16A7; the disease is cancer.